BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Pharm Country

  Optinose Announces Proposed Public Offering of Common Stock

  Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that it and certain selling stockholders intend to offer and sell shares of its common stock in an underwritten public offering.

  November 20, 2019

   · 

  4 min read
• Biotech Beach

  Illumina to Webcast Upcoming Investor Conference Presentations on December 2019

  Illumina, Inc. announced that its executives will be speaking at the following investor conferences and invited investors to participate via webcast.

  November 20, 2019

   · 

  1 min read
• Deals

  The American Academy of Orthopaedic Surgeons Makes Strategic Investment in Biologics Research and Development

  The American Academy of Orthopaedic Surgeons announced a strategic investment in the field of biologics.

  November 20, 2019

   · 

  2 min read
• Deals

  CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares at $64.50 per share

  CRISPR Therapeutics announced the pricing of an underwritten public offering of 4,250,000 common shares at a public offering price of $64.50 per share.

  November 20, 2019

   · 

  4 min read